Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy-like mice

Journal of Physiology

Volumn 590, Issue 22, 2012, Pages 5907-5925

  Biondi, Olivier ^a   Lopes, Philippe ^a,b   Desseille, Céline ^a   Branchu, Julien ^a   Chali, Farah ^a   Salah, Amina Ben ^a   Pariset, Claude ^a   Chanoine, Christophe ^a   Charbonnier, Frédéric ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC DYSFUNCTION; BRADYCARDIA; BREATHING RATE; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; EXERCISE; HEART ARRHYTHMIA; HEART CONDUCTION; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART RATE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPINAL MUSCULAR ATROPHY; WESTERN BLOTTING;

ANIMALS; BRADYCARDIA; CONTRACTILE PROTEINS; FIBROSIS; GENE EXPRESSION; HEART VENTRICLES; MICE; MICE, TRANSGENIC; PHYSICAL EXERTION; RUNNING; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; SURVIVAL OF MOTOR NEURON 1 PROTEIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 84869794844     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.238196     Document Type: Article

References (56)

1. Adamcova M & Pelouch V (1999). Isoforms of troponin in normal and diseased myocardium. Physiol Res 48, 235-247.
2. Allen DL, Harrison BC, Maass A, Bell ML, Byrnes WC & Leinwand LA (2001). Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol 90, 1900-1908.
3. Alpert NR, Brosseau C, Federico A, Krenz M, Robbins J & Warshaw DM (2002). Molecular mechanics of mouse cardiac myosin isoforms. Am J Physiol Heart Circ Physiol 283, H1446-H1454.
4. Arai H, Tanabe Y, Hachiya Y, Otsuka E, Kumada S, Furushima W, Kohyama J, Yamashita S, Takanashi J & Kohno Y (2005). Finger cold-induced vasodilatation, sympathetic skin response, and R-R interval variation in patients with progressive spinal muscular atrophy. J Child Neurol 20, 871-875.
5. Araujo Ade Q, Araujo M & Swoboda KJ (2009). Vascular perfusion abnormalities in infants with spinal muscular atrophy. J Pediatr 155, 292-294.
6. Bach JR (2007). Medical considerations of long-term survival of Werdnig-Hoffmann disease. Am J Phys Med Rehabil 86, 349-355.
7. Bach JR (2012). Noninvasive respiratory management of high level spinal cord injury. J Spinal Cord Med 35, 72-80.
8. Baudrie V, Laude D & Elghozi JL (2007). Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice. Am J Physiol Regul Integr Comp Physiol 292, R904-R912.
9. Bernardi L, Porta C, Gabutti A, Spicuzza L & Sleight P (2001). Modulatory effects of respiration. Auton Neurosci 90, 47-56.
10. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG & Mendelsohn ME (1997). Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest 99, 570-576.
11. Bevan AK, Hutchinson KR, Foust KD, Braun L, McGovern VL, Schmelzer L, Ward JG, Petruska JC, Lucchesi PA, Burghes AH & Kaspar BK (2010). Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet 19, 3895-3905.
12. Billman GE (2002). Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention. J Appl Physiol 92, 446-454.
13. Biondi O, Grondard C, Lecolle S, Deforges S, Pariset C, Lopes P, Cifuentes-Diaz C, Li H, della Gaspera B, Chanoine C & Charbonnier F (2008). Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 28, 953-962.
14. Chai Y, Zhang DM & Lin YF (2011). Activation of cGMP-dependent protein kinase stimulates cardiac ATP-sensitive potassium channels via a ROS/calmodulin/CaMKII signaling cascade. PLoS One 6, e18191.
15. Cranefield PF, Wit AL & Hoffman BF (1972). Conduction of the cardiac impulse. 3. Characteristics of very slow conduction. J Gen Physiol 59, 227-246.
16. De Angelis K, Wichi RB, Jesus WR, Moreira ED, Morris M, Krieger EM & Irigoyen MC (2004). Exercise training changes autonomic cardiovascular balance in mice. J Appl Physiol 96, 2174-2178.
17. De Meersman RE (1993). Heart rate variability and aerobic fitness. Am Heart J 125, 726-731.
18. Dixon EM, Kamath MV, McCartney N & Fallen EL (1992). Neural regulation of heart rate variability in endurance athletes and sedentary controls. Cardiovasc Res 26, 713-719.
19. Drummond GB (2009). Reporting ethical matters in the Journal of Physiology: standards and advice. J Physiol 587, 713-719.
20. Eckberg DL (1997). Baroreflexes and the failing human heart. Circulation 96, 4133-4137.
21. El-Khodor BF, Edgar N, Chen A, Winberg ML, Joyce C, Brunner D, Suarez-Farinas M & Heyes MP (2008). Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy. Exp Neurol 212, 29-43.
22. Everett AW, Sinha AM, Umeda PK, Jakovcic S, Rabinowitz M & Zak R (1984). Regulation of myosin synthesis by thyroid hormone: relative change in the alpha- and beta-myosin heavy chain mRNA levels in rabbit heart. Biochemistry 23, 1596-1599.
23. Gardner PI, Ursell PC, Fenoglio JJ, Jr & Wit AL (1985). Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 72, 596-611.
24. Grondard C, Biondi O, Armand AS, Lecolle S, Della Gaspera B, Pariset C, Li H, Gallien CL, Vidal PP, Chanoine C & Charbonnier F (2005). Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 25, 7615-7622.
25. Hachiya Y, Arai H, Hayashi M, Kumada S, Furushima W, Ohtsuka E, Ito Y, Uchiyama A & Kurata K (2005). Autonomic dysfunction in cases of spinal muscular atrophy type 1 with long survival. Brain Dev 27, 574-578.
26. Hall GH (2008). Exercise ECGs in angina. Which "angiographic positives" will die from heart disease BMJ 337, a3100.
27. Harada K, Sugaya T, Murakami K, Yazaki Y & Komuro I (1999). Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 100, 2093-2099.
28. Hayano J & Yasuma F (2003). Hypothesis: respiratory sinus arrhythmia is an intrinsic resting function of cardiopulmonary system. Cardiovasc Res 58, 1-9.
29. Heier CR, Satta R, Lutz C & DiDonato CJ (2010). Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet 19, 3906-3918.
30. Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH & Li H (2000). A mouse model for spinal muscular atrophy. Nat Genet 24, 66-70.
31. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA & Robbins J (1996). Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 98, 1906-1917.
32. Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, Landmesser LT & Monani UR (2008). Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet
33. Kong L, Wang X, Choe DW, Polley M, Burnett BG, Bosch-Marce M, Griffin JW, Rich MM & Sumner CJ (2009). Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 29, 842-851.
34. Kostova FV, Williams VC, Heemskerk J, Iannaccone S, Didonato C, Swoboda K & Maria BL (2007). Spinal muscular atrophy: classification, diagnosis, management, pathogenesis, and future research directions. J Child Neurol 22, 926-945.
35. Krenz M, Sanbe A, Bouyer-Dalloz F, Gulick J, Klevitsky R, Hewett TE, Osinska HE, Lorenz JN, Brosseau C, Federico A, Alpert NR, Warshaw DM, Perryman MB, Helmke SM & Robbins J (2003). Analysis of myosin heavy chain functionality in the heart. J Biol Chem 278, 17, 466-17, 474.
36. Lompre AM, Nadal-Ginard B & Mahdavi V (1984). Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem 259, 6437-6446.
37. Martinez-Hernandez R, Soler-Botija C, Also E, Alias L, Caselles L, Gich I, Bernal S & Tizzano EF (2009). The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J Neuropathol Exp Neurol 68, 474-481.
38. McGovern VL, Gavrilina TO, Beattie CE & Burghes AH (2008). Embryonic motor axon development in the severe SMA mouse. Hum Mol Genet
39. Michaud M, Arnoux T, Bielli S, Durand E, Rotrou Y, Jablonka S, Robert F, Giraudon-Paoli M, Riessland M, Mattei MG, Andriambeloson E, Wirth B, Sendtner M, Gallego J, Pruss RM & Bordet T (2010). Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol Dis 38, 125-135.
40. Mitchell GF, Jeron A & Koren G (1998). Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol Heart Circ Physiol 274, H747-H751.
41. Nguyen L, Chung J, Lam L, Tsoutsman T & Semsarian C (2007). Abnormal cardiac response to exercise in a murine model of familial hypertrophic cardiomyopathy. Int J Cardiol 119, 245-248.
42. Niskanen JP, Tarvainen MP, Ranta-Aho PO & Karjalainen PA (2004). Software for advanced HRV analysis. Comput Methods Programs Biomed 76, 73-81.
43. Oskoui M & Kaufmann P (2008). Spinal muscular atrophy. Neurotherapeutics 5, 499-506.
44. Samaha FJ, Buncher CR, Russman BS, White ML, Iannaccone ST, Barker L, Burhans K, Smith C, Perkins B & Zimmerman L (1994). Pulmonary function in spinal muscular atrophy. J Child Neurol 9, 326-329.
45. Sato S (2008). Quantitative evaluation of ontogenetic change in heart rate and its autonomic regulation in newborn mice with the use of a noninvasive piezoelectric sensor. Am J Physiol Heart Circ Physiol 294, H1708-H1715.
46. Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA & Lorson CL (2010). Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet 19, 4059-4071.
47. Smith ML, Hudson DL, Graitzer HM & Raven PB (1989). Exercise training bradycardia: the role of autonomic balance. Med Sci Sports Exerc 21, 40-44.
48. Stoica P & Moses RL (1997). Introduction to Spectral Analysis. Prentice Hall, New Jersey, ISBN: 0-13-258419-0.
49. Sveen ML, Jeppesen TD, Hauerslev S, Kober L, Krag TO & Vissing J (2008). Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 131, 2824-2831.
50. Swoap SJ, Li C, Wess J, Parsons AD, Williams TD & Overton JM (2008). Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality. Am J Physiol Heart Circ Physiol 294, H1581-H1588.
51. Task Force (1996). Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17, 354-381.
52. Thireau J, Zhang BL, Poisson D & Babuty D (2008). Heart rate variability in mice: a theoretical and practical guide. Exp Physiol 93, 83-94.
53. Towbin H, Schoenenberger C, Ball R, Braun DG & Rosenfelder G (1984). Glycosphingolipid-blotting: an immunological detection procedure after separation by thin layer chromatography. J Immunol Methods 72, 471-479.
54. Tsoutsman T, Bagnall RD & Semsarian C (2008). Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure. Clin Exp Pharmacol Physiol 35, 1349-1357.
55. Tsoutsman T, Chung J, Doolan A, Nguyen L, Williams IA, Tu E, Lam L, Bailey CG, Rasko JE, Allen DG & Semsarian C (2006). Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 41, 623-632.
56. Yotsukura M, Fujii K, Katayama A, Tomono Y, Ando H, Sakata K, Ishihara T & Ishikawa K (1998). Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy. Am Heart J 136, 289-296.